Test Overview
Test Methodology

Molecular counting technology

Test Usage

Non-invasive prenatal screening that assesses fetal risk for aneuploidies, recessive conditions and fetal antigens from a maternal blood draw at 10+ weeks into pregnancy. Does not require a paternal sample.

Reference Range *

Interpretive report provided

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Details
Days Set Up
Monday - Friday
Analytic Time

10 - 21 days

Soft Order Code
UNICS
Synonyms
    Laboratory
    Sendout
    Reference Laboratory
    BillionToOne
    Section
    Special Testing
    Specimen Requirements
    Collection Instructions

    Collect specimen in Streck tubes in the kit provided by the FDC. Send to Specimen Processing room temp along with all the materials in the kit

    Normal Volume
    10 mL whole blood
    Minimum Volume
    8 mL whole blood
    Storage Temperature
    Ambient
    Additional Information

    Test is performed by BillionToOne Inc

    Billing
    NY State Approved
    No